MD Pediatrix Medical Group, Inc.
FY2025 10-K
Pediatrix Medical Group, Inc. (MD) filed its fiscal year 2025 10-K annual report with the SEC on Feb 19, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business model: provider of neonatal and pediatric healthcare services
- • No new products, services, or segments introduced or emphasized this year
Management Discussion & Analysis
- • Revenue details and YoY change not disclosed in provided text
- • Profitability or margin changes not specified in provided text
Risk Factors
- • Regulatory/legal risk: potential audit, inquiry, or investigation impact on revenue from government agencies over $1.15B gross receivables and DSO 42.8 days
- • Geopolitical/macro risk: 32% of net revenue concentrated in Texas exposing Pediatrix to regional health policy or economic shifts
Financial SummaryXBRL
Revenue
$1.9B
Net Income
$165M
Operating Margin
10.9%
Net Margin
8.6%
ROE
19.1%
Total Assets
$2.2B
EPS (Diluted)
$1.94
Operating Cash Flow
$271M
Source: XBRL data from Pediatrix Medical Group, Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Pediatrix Medical Group, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.